Intellectual Property

  • April 17, 2025

    Hyundai Can Seek Atty Fees On Withdrawn Ad Patents

    A California federal judge on Thursday declared Hyundai the prevailing party in litigation brought against it by StratosAudio Inc. after the Federal Circuit declared StratosAudio's advertising patents invalid, and said the automaker could file a motion seeking attorney fees on two other patents voluntarily withdrawn from the case.

  • April 17, 2025

    AstraZeneca Unit Hit With Antitrust Suit Over Soliris

    Not-for-profit insurance company EmblemHealth Inc. has hit an AstraZeneca unit with a proposed class action claiming the subsidiary defrauded the U.S. Patent and Trademark Office to delay generic competition of its blood disorder product Soliris.

  • April 17, 2025

    Stites & Harbison Adds 4th Cantor Colburn IP Atty In Conn.

    A little over six months after Stites & Harbison PLLC launched its new outpost in Connecticut with a three-attorney team from Cantor Colburn LLP, a fourth lawyer has made the jump to join Stites & Harbison's intellectual property and technology service group in Hartford, the firm has said.

  • April 17, 2025

    'Moonshine' Fudge Maker Must Pay Fees For Failed IP Claims

    The maker of "Chocolate Moonshine" fudge may have won a trade secrets case against his ex-wife and her new chocolate company, but he must pay the defendants more than $174,000 in attorney fees and costs for his unsuccessful trademark and copyright infringement claims.

  • April 17, 2025

    Fed. Circ. Won't Revive Network Tech Patent Suit

    The Federal Circuit on Thursday upheld a lower court's finding that Seattle-based technology company F5 did not infringe a patent owned by WSOU Investments LLC covering a network traffic distribution technology.

  • April 17, 2025

    Music Royalties Co. Hipgnosis Revives UK Fight With Manilow

    British music royalties firm Hipgnosis can forge ahead with its unpaid royalties case against singer Barry Manilow in the U.K., after an appellate panel on Thursday overturned a pause imposed because of parallel proceedings in Los Angeles.

  • April 17, 2025

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen the producers of West End show "Elf the Musical" face a contract dispute, Korean biotech company ToolGen Inc. bring a fresh patents claim against pharma giant Vertex, and ousted car tycoon Peter Waddell bring a claim against the private equity firm that backed his business. Here, Law360 looks at these and other new claims in the U.K.

  • April 16, 2025

    Fed. Circ. Won't Touch Meta's PTAB Win Against Xerox

    A Federal Circuit panel on Wednesday quickly and without comment rejected a bid from Xerox Corp. to overturn a Patent Trial and Appeal Board decision in favor of Meta Platforms Inc. that found claims in a message distribution patent are invalid.

  • April 16, 2025

    Pa. Poultry Farm's Slaughter Methods Deemed Trade Secrets

    The Pennsylvania Superior Court has ruled that an animal rights group cannot force a Lebanon County poultry farm to disclose its chicken slaughtering practices, with the court ruling that the materials sought were confidential trade secrets.

  • April 16, 2025

    Ye Says DJ Khalil Is Fishing For Profits In 'Donda' IP Lawsuit

    The artist formerly known as Kanye West denied derailing discovery in a lawsuit alleging he stole music from DJ Khalil and three other artists for two tracks on his blockbuster "Donda" album, telling a California federal judge Tuesday that the $50,000 sanctions bid is just a "profit-driven fishing expedition."

  • April 16, 2025

    Texas Ranch Neighbor Agrees Not To Use 'Mesa Vista' Name

    The owner of a property neighboring the late T. Boone Pickens' luxurious Mesa Vista Ranch hunting estate in the Texas Panhandle has agreed to stop using the name after being sued by the ranch's new owner.

  • April 16, 2025

    AlmondNet Sues Amazon Again After $136M Ad IP Victory

    AlmondNet Inc. is aiming to expand on the $136 million it already won against Amazon for patent infringement with a new suit in Texas federal court accusing the technology giant of infringing another patent tied to directing television advertisements.

  • April 16, 2025

    AT&T Gets $450M 'Twinning' Patent Suit Tossed Again

    A New York federal judge has held that it is only fitting that she rule twice on a motion to dismiss a $450 million patent lawsuit against AT&T over so-called twinning phone technology, deciding yet again that the patent is not inventive enough to be worth anything.

  • April 16, 2025

    New USPTO Group To Target Fraud In Patent Applications

    The U.S. Patent and Trademark Office announced new efforts Wednesday to combat fraudulent patent application activity, such as false signatures on filings and attempts to claim undeserved fee discounts, saying the moves will protect the integrity of the patent system.

  • April 16, 2025

    Fed. Circ. Won't Revive MIT Patent In Electric Vehicle Fight

    The Federal Circuit on Wednesday refused to revive a technology company's patent covering a wireless charging system created by the Massachusetts Institute of Technology, backing a Patent Trial and Appeal Board finding that the challenged claims were too obvious to warrant patent protection.

  • April 16, 2025

    9th Circ. Won't Revive Ex-Beach Boy Guitarist's Royalty Fight

    The Ninth Circuit refused to reinstate a former Beach Boys guitarist's suit that sought to revoke his royalty agreements with Universal Music Group since they were based on physical record sales and didn't contemplate the evolution of digital streaming, ruling Wednesday the contracts only paid for physical record sale royalties.

  • April 16, 2025

    Greek IT Co.'s Suit Over Leaked Patent Info Gets Tossed

    A New York federal judge has tossed a Greece-based technology company's suit alleging Ladas & Parry LLP sent proprietary information to a third party while the company had an attorney-client agreement with the firm.

  • April 16, 2025

    Bradley Arant Lands 12-Member Morris Manning IP Team

    Bradley Arant Boult Cummings LLP has hired a 12-person intellectual property team from Morris Manning & Martin LLP for its Atlanta office.

  • April 16, 2025

    Sterlington Adds Ex-Loeb & Loeb PTAB Trials Head In Calif.

    International law firm Sterlington PLLC has added a partner who has guided clients in more than 140 proceedings before the U.S. Patent Trial and Appeal Board, strengthening its intellectual property practice with the former chair of Loeb & Loeb's PTAB trials practice, the firm announced Wednesday.

  • April 16, 2025

    Texas Law Firm Hits Rival With Web Search Keywords Suit

    Texas personal injury firm Thomas J. Henry Law has claimed in a lawsuit filed in Texas federal court that a Lone Star State competitor is unlawfully capitalizing on his reputation by misdirecting web searches through the purchase of certain search keywords.

  • April 16, 2025

    X Corp. On The Hook For $105M In Video IP Row, Jury Finds

    X Corp. will have to cough up $105 million after a Dallas jury found Wednesday that it infringed a startup company's video sharing technology, awarding significantly less than the $632 million that the patent owner VidStream LLC had sought.

  • April 16, 2025

    NC Hospital Beats Weight Loss Clinic's Trademark Suit

    A North Carolina federal judge tossed a Tar Heel State weight loss clinic's trademark infringement suit, calling the clinic's mark "relatively weak" and finding it has "very little similarity" to the purportedly infringing mark used by the hospital and healthcare provider it sued.

  • April 16, 2025

    Jack Nicklaus Granted $1M In Damages After NIL Win

    Jack Nicklaus was granted $1 million Wednesday by a New York state court judge for damages incurred as a result of a preliminary injunction that prevented the golf legend from signing new commercial deals during now-dismissed litigation over the use of his name, image and likeness.

  • April 15, 2025

    Astellas Bladder Drug Patent Survives Following Bench Trial

    A Delaware federal judge on Tuesday held that generic-drug makers Lupin and Zydus Pharmaceuticals haven't shown "by clear and convincing evidence" that an Astellas Pharma patent covering the bladder medication Myrbetriq is invalid.

  • April 15, 2025

    Biogen, Genentech Head To June Trial Over MS Drug Royalties

    A California federal judge on Tuesday denied Biogen's bid for summary judgment in a high-stakes contract fight with Roche Holding AG subsidiary Genentech over patent royalties on multiple sclerosis drug sales, saying during a hearing that there's a material dispute over the contract's language and the case will be tried in June.

Expert Analysis

  • What Public View Of CEO's Killing Means For Corporate Trials

    Author Photo

    Given the proliferation of anti-corporate sentiments following recent charges against Luigi Mangione in connection with the killing of UnitedHealthcare's CEO, attorneys who represent corporate clients and executives will need to adapt their trial strategy to account for juror anger, says Clint Townson at Townson Litigation Consulting.

  • Private-Bidding Compliance Lessons From Siemens Plea Deal

    Author Photo

    Siemens Energy’s recent wire fraud conspiracy guilty plea shows that U.S. prosecutors are willing and able to police the private, domestic bidding market to protect the integrity of the competitive marketplace, and companies will need a robust compliance program to mitigate these risks, say attorneys at Foley Hoag.

  • Lessons From The Pharma Industry On Patent Cliffs

    Author Photo

    In the next five years, patents for drugs that have generated billions in global sales are set to expire, and companies that view this imminent patent cliff as an opportunity for strategic renewal rather than a challenge will be best positioned to maintain market leadership, says Keegan Caldwell at Caldwell Law.

  • FTC Report On AI Sector Illuminates Future Enforcement

    Author Photo

    The Federal Trade Commission's report on cloud service providers and their partnerships with developers of artificial intelligence's large language models suggests that the agency will move to rein in Big Tech with antitrust enforcement to protect startups, say attorneys at Squire Patton.

  • Artfully Conceding Liability Can Offer Defendants 3 Benefits

    Author Photo

    In the rare case that a company makes the strategic decision to admit liability, it’s important to do so clearly and consistently in order to benefit from the various forms of armor that come from an honest acknowledgment, says Ken Broda-Bahm at Persuasion Strategies.

  • Mentorship Resolutions For The New Year

    Author Photo

    Attorneys tend to focus on personal achievements or career milestones when they set yearly goals, but one important area often gets overlooked in this process — mentoring relationships, which are some of the most effective tools for professional growth, say Kelly Galligan at Rutan & Tucker and Andra Greene at Phillips ADR.

  • What Nearshoring Growth In Americas Means For Patents

    Author Photo

    With the new U.S. administration potentially focused on implementing draconian trade restrictions, nearshoring in the Americas is expected to grow, and patent prosecution attorneys will be kept on their toes as the patent landscape from country to country continues to evolve, says Ernest Huang at Procopio.

  • Series

    Coaching Little League Makes Me A Better Lawyer

    Author Photo

    While coaching poorly played Little League Baseball early in the morning doesn't sound like a good time, I love it — and the experience has taught me valuable lessons about imperfection, compassion and acceptance that have helped me grow as a person and as a lawyer, says Alex Barnett at DiCello Levitt.

  • Influencer IP Case Risks Judges Becoming Arbiters Of 'Vibes'

    Author Photo

    The case of Gifford v. Sheil, pending in Texas federal court, involves an influencer alleging that distinctive social media aesthetics constitute protectable property, and reflects a troubling trend: the overreach of intellectual property law in areas better left for creative freedom, say attorneys at Holland & Knight.

  • 5 Litigation Funding Trends To Note In 2025

    Author Photo

    Lawyers and their clients must be prepared to navigate an evolving litigation funding market in 2025, made more complicated by a new administration and the increasing overall cost of litigation, says Jeffery Lula at GLS Capital.

  • A Look At FDA's Plans To Establish New OTC Drug Category

    Author Photo

    The U.S. Food and Drug Administration's recently finalized rule, creating a new over-the-counter pathway for drugs when patients satisfy certain conditions, may be useful for off-patent drugs with established safety records, though switching to OTC comes with additional costs and considerations, say attorneys at Skadden.

  • The Fed. Circ. In 2024: 5 Major Rulings To Know

    Author Photo

    In 2024, the Federal Circuit provided a number of important clarifications to distinct areas of patent law – including design patent obviousness, expert testimony admissions and patent term adjustments – all of which are poised to have an influence going forward, say attorneys at Knobbe Martens.

  • Rethinking Litigation Risk And What It Really Means To Win

    Author Photo

    Attorneys have a tendency to overestimate litigation risk before summary judgment and underestimate risk after it, but an eight-stage litigation framework can clarify risk at different points and help litigators reassess what true success looks like in any particular case, says Joshua Libling at Arcadia Finance.

  • Patent Ruling Sheds Light On Printed Matter Doctrine

    Author Photo

    Patent attorneys should pay attention to the claim language highlighted in Ioengine v. Ingenico, where the Federal Circuit held that program code was not printed matter, but essentially instructions or content, and therefore not subject to the printed matter doctrine for patent challenges, says Irah Donner at Manatt.

  • How DOGE's Bite Can Live Up To Its Bark

    Author Photo

    All signs suggest that the Department of Government Efficiency will be an important part of the new Trump administration, with ample tools at its disposal to effectuate change, particularly with an attentive Republican-controlled Congress, say attorneys at K&L Gates.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!